Qualitas Funds has announced that Develco Pharma has been added to the Qualitas Funds Direct II portfolio. This transaction was led by one of their managers located in Germany.

Develco Pharma is a specialty pharmaceutical company that develops and produces innovative formulations for drugs with known active ingredients. After approval, the products are licensed out to internationally operating pharmaceutical companies. Develco Pharma is responsible for the entire value chain, from development and approval, to manufacture and delivery. By focusing on extended or modified releases, the company has grown into an internationally recognized and renowned provider.

Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

ART Technologies Raises €200,000 from ...

by REDIT Ventures

ART Technologies, a Valencia-based startup specializing in hyperspectr...

Photos Stream